| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2008 | WO2007078726A3 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 06/12/2008 | WO2007073194A3 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/12/2008 | WO2007068895A9 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 06/12/2008 | WO2007058538A3 Composition with docosapentaenoic acid |
| 06/12/2008 | WO2007005879A3 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 06/12/2008 | WO2006138487A3 Treatment of ischemia-induced arrhythmias |
| 06/12/2008 | WO2005046434A8 Compositions and methods for diagnosing and treating mental disorders |
| 06/12/2008 | US20080140450 Treatment of metabolic syndrome with norfluoxetine |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080140036 Antimicrobial Composition |
| 06/12/2008 | US20080139815 Drug conjugates |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139809 Compounds Capable of Activating Cholinergic Receptors |
| 06/12/2008 | US20080139808 Crystal forms of lamotrigine and processes for their preparations |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139765 Polymers having improved cosmetic wear properties |
| 06/12/2008 | US20080139669 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 06/12/2008 | US20080139668 Pharmaceutical composition for obovatol for the prevention and treatment of restenosis |
| 06/12/2008 | US20080139667 Pharmaceutical Compositions For the Treatment of Disease and/or Symptoms in Arthritis |
| 06/12/2008 | US20080139666 Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues |
| 06/12/2008 | US20080139665 Modulating activity of lysine specific demethylase with amine oxidase inhibitors; regulating cell growth and differentiation |
| 06/12/2008 | US20080139664 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 06/12/2008 | US20080139663 Cycloalkylmethylamine analogs; use treating obesity or related co-morbid indications |
| 06/12/2008 | US20080139662 Such as 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| 06/12/2008 | US20080139660 Tablets comprising entacapone and crospovidone |
| 06/12/2008 | US20080139659 Reducing intracranial pressure with sulfonylurea receptor 1 antagonist |
| 06/12/2008 | US20080139657 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)hydroxycitric acid, and related compositions thereof |
| 06/12/2008 | US20080139655 Consistant activation of brain dopamine receptors over time; reduced side effects from prolonged therapy; oral Parkinson's disease dosage form |
| 06/12/2008 | US20080139654 Lower dosage; combined with glutathione production promoter; formulated to decrease emesis |
| 06/12/2008 | US20080139653 Prodrug with ornithine and/or homoarginine; maintaining controlled blood level concentration over time; eliminating euphoria effect and cardiovascular stress; attention deficit disorders, hyperactivity, obesity, narcolepsy, appetite suppression, depression, anxiety |
| 06/12/2008 | US20080139652 Pharmaceutical Composition Containing Prostaglandin |
| 06/12/2008 | US20080139651 Compounds useful for treating neurological disorders |
| 06/12/2008 | US20080139649 Fatty Acid-Benzenediol Derivatives and Methods of Making and Using Thereof |
| 06/12/2008 | US20080139648 Product Containing Prostaglandin Having Fluorine Atom In Its Molecule |
| 06/12/2008 | US20080139646 Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof |
| 06/12/2008 | US20080139645 Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents |
| 06/12/2008 | US20080139644 Composition comprising (-)-delta9-trans-tetrahydrocannabinol |
| 06/12/2008 | US20080139642 Aryl ethers of dihydroartemisnin such as 4-methoxycarbonylmethyl phenyl-dihydroartemisinine ether; immunosuppressants; dosage forms including tablets, ointments and suppositories; side effect reduction over cyclosporin A |
| 06/12/2008 | US20080139641 Local anesthetic free; dentistry; side effect reduction |
| 06/12/2008 | US20080139640 Hydroxamates, Their Manufacture And Use As Pharmaceutical Agents |
| 06/12/2008 | US20080139639 Proton Pump Inhibitors |
| 06/12/2008 | US20080139638 Method of increasing growth hormone secretion |
| 06/12/2008 | US20080139637 Reacting an alpha,beta-unsaturated compound and indole or indole derivative with a lewis acid catalyst; industrial scale synthesis of 1,1,3-tris(indol-3-yl)cyclohexane for example; treating cancer cells with the mutation of the p53 tumor suppressor gene |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139635 Inflammation Therapy |
| 06/12/2008 | US20080139634 Use against hormone refractory prostate cancer; 1-(3-trifluoromethyl-4-cyanophenyl)-2-thioxo-3-(substituted phenyl)-imidazolidin-5-one and spiro ring derivatives thereof; androgen receptor antagonists with minimal agonist activity |
| 06/12/2008 | US20080139633 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/12/2008 | US20080139632 Such as 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-2-hydroxybenzoic acid for modulating premature translation termination or nonsense-mediated mRNA decay in cells |
| 06/12/2008 | US20080139631 3-(2-methyl-4-(trifluoromethyl)-5-cyano-indol-1-yl-methyl)-5-(3-(trifluoromethyl)phenyl)-1,2,4-oxadiazole or salt thereof; hypogonadism, sarcopenia, osteoporosis, wasting diseases, cancer cachexia, frailty, prostatic hyperplasia, prostate cancer, breast cancer; selective androgen receptor modulators |
| 06/12/2008 | US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 06/12/2008 | US20080139629 Administering an organic arsenical compound such as S-dipropylarsinyl-1-thioglycerol; anticancer, antitumor, psoriasis, retinopathy, arthritis |
| 06/12/2008 | US20080139628 Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial Agonists |
| 06/12/2008 | US20080139627 Heterocyclic amide and imine derivatives, processes for their preparation, compositions comprising them and their use as pesticides |
| 06/12/2008 | US20080139626 Novel Method |
| 06/12/2008 | US20080139625 Pyrrolidin-2-One and Piperidin-2-One Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 06/12/2008 | US20080139624 Pellets; sustained release |
| 06/12/2008 | US20080139623 Amorphous and crystalline forms of pantoprazole magnesium salt |
| 06/12/2008 | US20080139622 Decahydronaphthalene Compounds |
| 06/12/2008 | US20080139621 Thrombocytopenia; administering a thrombopoietin receptor agonist; 4-(2-hydroxyphenyl)piperidin-1-yl-acetic acid; 3-(2-hydroxyphenyl)cyclohexane-carboxylic acid; 3-(3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-phenyl)cyclohexane-1-carboxylic acid |
| 06/12/2008 | US20080139620 Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's |
| 06/12/2008 | US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments |
| 06/12/2008 | US20080139618 Indoles |
| 06/12/2008 | US20080139617 Indoles |
| 06/12/2008 | US20080139616 Atherosclerosis; inflammatory diseases, Alzheimer's disease, dyslipidemia, metabolic syndrome; 2-isopropyl-5-phenyl-4-[(4-phenylbutyl)amino]isothiazole-3(2H)-thione 1,1-dioxide for example |
| 06/12/2008 | US20080139615 Combination of a hypnotic agent and r (+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and therapeutic application thereof |
| 06/12/2008 | US20080139614 Treatment Of Stroke With Histamine H3 Inverse Agonists Or Histamine H3 Antagonists |
| 06/12/2008 | US20080139613 4-{(1R,3R)-1-(3,5-difluorophenyl)-3-[4-(3-ethyl-5-isopropyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl]butyl}-1-(methylsulfonyl)piperidine; for treatment of CCR5 disease states |
| 06/12/2008 | US20080139612 Chemical Compound |
| 06/12/2008 | US20080139611 Use of [2-(7-Trifluoromethyl-quinolin-4-ylamino)-phenyl]-acetic acid or esters or salts thereof for example; pain, fever, or inflammation, a proliferative disorder, skin disorders, eye disorders; compound disclosed in US patent 3,637,710 |
| 06/12/2008 | US20080139610 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 06/12/2008 | US20080139609 Paraben preservatives; sterilized by heat exposure |
| 06/12/2008 | US20080139608 2,6,8, Trisubstituted 1-deazapurines and their different uses |
| 06/12/2008 | US20080139607 Inhibitors of the serine protease PAI-1 (plasminogen activator inhibitor type 1); (3R)-8-(3,4-Difluoro-phenyl)-7-heptyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid for example; desulfurization to form corresponding 1-(1-carboxyethyl)-1,2-dihydro-2-oxopyridine compound; coadministering |
| 06/12/2008 | US20080139606 Substituted Pyrrolopyridines, Compositions Containing Them, Manufacturing Process Therefor and Use Thereof |
| 06/12/2008 | US20080139605 Substituted prolinamides, manufacturing, and the use thereof as medicaments |
| 06/12/2008 | US20080139604 Administering nicotinic acid and/or prostaglandin D2 receptor agonist; simvastatins; eliminates flushing |
| 06/12/2008 | US20080139603 Azabicycloalkane compounds |
| 06/12/2008 | US20080139602 e.g. 5-{3-[4-(4-Chloro-phenyl)-4-hydroxy-3,3-dimethyl-piperidin-1-yl]-propylidene}-1-oxy-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cycloheptene-7-carboxylic acid; chemokine receptor antagonist; antiinflammatory, antidiabetic agent; antiallergen; arteriosclerosis, asthma, arthritis |
| 06/12/2008 | US20080139601 3-Cyano-Quinoline Derivatives With Antiproliferative Activity |
| 06/12/2008 | US20080139600 e.g. N,N-dimethyl-1-{5-[(2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridin]-5'-yl]-2-thienyl}methenamine; anxiolytic agent, antidepressant, cognition activator; neurodegenerative disorders: Alzheimer's, Parkinson's, Huntington's diseases, Tourette's syndrome, schizophrenia |
| 06/12/2008 | US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation |
| 06/12/2008 | US20080139598 e.g. N-(3'-chloro-3-methylbiphenyl-4-yl)-1-(pyrimidin-2-yl)piperidin-4-amine; proline transporter inhibitor; cognition activator; Alzheimer's disease, Attention-Deficit/Hyperactivity Disorder, autism, Down syndrome, Fragile X syndrome, Huntington's disease, Parkinson's disease, schizophrenia, dementia |
| 06/12/2008 | US20080139597 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 06/12/2008 | US20080139596 Modulators of Hcv Replication |
| 06/12/2008 | US20080139595 Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors |
| 06/12/2008 | US20080139594 e.g. 4-[8-Chloro-2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]-n-phenylpyrimidin-2-amine; synthesis |
| 06/12/2008 | US20080139593 Administering ambrisentan to subject, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years; pulmonary arterial hypertension (PAH); chronic obstructive pulmonary disease; respiratory system, sleep, developmental and cardiovascular disorders |
| 06/12/2008 | US20080139592 Administering carboxyamidotriazole or 5-(amino)-1,2,3-triazole orotate as angiogenesis inhibitor; treatment of vision defects, retinopathy, neovascularization, blood disorder, leukemia, granuloma, arthritis, psoriasis; antidiabetic, antitumor, anticarcinogenric, antimetastasis, and wound healing agents; |
| 06/12/2008 | US20080139591 CGRP Antagonists |
| 06/12/2008 | US20080139590 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 06/12/2008 | US20080139589 2-Methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone; sleep, psychological, nervous system, and attention deficit disorders; drug abuse, alcoholism; antidiabetic agents, cognition activators; Alzheimer's and Parkinson's disease; histamine H3 receptor antagonists |
| 06/12/2008 | US20080139588 Pyrrolo[2,3-d]pyrimidine cytokine inhibitors |
| 06/12/2008 | US20080139587 Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof |
| 06/12/2008 | US20080139586 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction |
| 06/12/2008 | US20080139585 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian |
| 06/12/2008 | US20080139584 Administering calcium channel blocker such as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-dimethyl ester or derivative; hemorrheologic agent such as 1-(5-oxohexyl)-3,7-dimethylxanthine or salt; and 2-(2-ethoxy-ethoxy)-ethanol dermal penetration agent |
| 06/12/2008 | US20080139583 Phosphodiesterase 4 inhibitors |
| 06/12/2008 | US20080139582 Inhibitors of bruton's tyrosine kinase |
| 06/12/2008 | US20080139580 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 06/12/2008 | US20080139579 Hiv Integrase Inhibitors |